WHO recommends Eli Lilly, GSK-Vir's drugs, widening Covid-19 treatment pool

WHO recommends Eli Lilly, GSK-Vir's drugs, widening Covid-19 treatment pool - Hello loyal readers FeedGoogle, In the article you are reading this time with the title WHO recommends Eli Lilly, GSK-Vir's drugs, widening Covid-19 treatment pool, We have prepared this article well for you to read and take information in it. hopefully the contents of the post Article World, what we write you can understand. Alright, happy reading.

WHO strongly recommended Lilly's baricitinib, sold under brand name Olumiant, for patients with severe Covid-19 in combination with corticosteroids, while conditionally endorsed GSK-Vir's antibody therapy for non-severe patients at the highest risk of hospitalisation. — Reuters pic Follow us on Instagram and subscribe to our Telegram channel for the latest updates. GENEVA, Jan 14 ― A World Health Organisation (WHO) panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for Covid-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective.WHO data shows Omicron, which is evading protection provided by many vaccines and therapies, has been identified in 149 countries. It is quickly replacing Delta as the dominant variant in several nations, forcing governments and scientists to bolster defences wi…